Medication Brand Names Beginning with ‘F’, Page 65

Page 65 of 218 « First Page « … 5 10 15 20 25 … 63 64 65 66 67 … 70 75 80 85 90 … » Last Page »

Finasteride

Finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY. Efficacy in bitemporal recession has not been established. Finasteride…

Dr Reddys Laboratories Inc20 June 2018

Finasteride

Finasteride Tablets USP is a 5alpha-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to (1.1): Improve…

Ascend Laboratories, LLC3 February 2020

Finasteride

Finasteride, is a 5alpha-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to (1.1): Improve symptoms…

Proficient Rx LP1 February 2020

Finasteride

Finasteride tablets USP are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.Efficacy in bitemporal recession has not been established…

Preferred Pharmaceuticals Inc.21 May 2020

Finasteride

Finasteride, is a 5alpha-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to (1.1): Improve symptoms…

Preferred Pharmacetucals Inc.21 May 2020

Page 65 of 218 « First Page « … 5 10 15 20 25 … 63 64 65 66 67 … 70 75 80 85 90 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.